Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 USD | +6.37% | +16.78% | -15.23% |
03-28 | Transcript : Iterum Therapeutics plc, Q4 2023 Earnings Call, Mar 28, 2024 | |
03-28 | Iterum Therapeutics plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 14
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Dunne
FOU | Founder | 64 | 31/10/15 |
Corey N. Fishman
FOU | Founder | 59 | 23/06/15 |
Director of Finance/CFO | 54 | 31/10/15 | |
Tom Loughman
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/16 |
Steven Aronin
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/17 |
Chief Tech/Sci/R&D Officer | 55 | 12/12/21 | |
Louise Barrett
LAW | General Counsel | - | 31/12/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ron Hunt
CHM | Chairman | 59 | 31/10/15 |
Beth Hecht
BRD | Director/Board Member | 60 | 11/03/21 |
Corey N. Fishman
FOU | Founder | 59 | 23/06/15 |
Director/Board Member | 63 | 31/07/16 | |
Michael Dunne
FOU | Founder | 64 | 31/10/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 16,426,784 | 16,177,780 ( 98.48 %) | 0 | 98.48 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.23% | 27.43M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ITRM Stock
- Company Iterum Therapeutics plc